Opus Genetics, Inc.
IRD
$3.61
-$0.11-2.96%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 87.64% | -296.63% | 5.33% | -135.23% | 9.45% |
| Total Depreciation and Amortization | 7.69% | 0.00% | 0.00% | -7.14% | 7.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -109.19% | 700.98% | -36.55% | 19,025.45% | 89.40% |
| Change in Net Operating Assets | 1,075.49% | -239.73% | -91.66% | 131.16% | -855.10% |
| Cash from Operations | 6.11% | -29.43% | -59.70% | 40.04% | -14.18% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 139.19% | -87.72% | 364.27% | -- | -100.00% |
| Repurchase of Common Stock | 100.00% | 71.55% | -- | -- | 100.00% |
| Issuance of Preferred Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -245.56% | -267.35% | 85.92% | -640.43% | -100.67% |
| Cash from Financing | 48.23% | 14.46% | 430.68% | 401.43% | -95.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.73% | 4.15% | 984.51% | 82.76% | -181.62% |